Interim analysis (IA) of the giredestrant (G) + samuraciclib (SAMURA) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC).

Poster Bd #: 365P

Poster

Descargar poster

Autor
Mafalda Oliveira

Hospital Universitario Vall d’Hebron. Barcelona

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON